After the Spring Festival of the year of the tiger, a number of companies to be listed on the science and innovation board, which were suspended due to the filing and investigation of intermediaries by the CSRC, successively resumed the listing audit and continued to promote the IPO journey. As of February 11, 2022, there were 389 listed companies on the science and innovation board, with a total market value of 5.37 trillion; Among the 155 enterprises in the IPO queue on the science and innovation board, 12 have obtained the effective IPO registration, 4 have submitted the IPO registration, and 14 are suspended.
“the IPO will be terminated due to factors such as the business performance during the queuing period does not meet the requirements, the financial expiration date is not updated in time, and some matters are in doubt.” An investment banker from a small and medium-sized securities firm told the reporter of the science and Innovation Board daily that although the IPO cycle is shortened after the implementation of the quasi registration system and the science and Innovation Board focuses on the attributes of enterprise science and innovation, the issuance and examination requirements are as strict as the main board.
According to the incomplete statistics of xingkuang data, 109 IPO companies have terminated the audit since the establishment of Kechuang board. among them, 88 withdrew voluntarily, 9 were terminated because they were not approved by the issuance and examination committee, and 12 were terminated in the IPO registration stage.
As of February 11, four companies that have voluntarily withdrawn, such as Zhongyan Co., Ltd. and Jingyun pharmaceutical, have re registered for IPO counseling, and launched an assault on the science and innovation board again. Maolai optics, core vision and other enterprises’ IPO sites have changed from the science and innovation board to the main board or gem, and Ruineng semi director and others are trying to backdoor listing.
Excluding the enterprises that have been queued up again, the remaining 105 IPO enterprises to be listed on the science and innovation board take an average of 212.85 days from acceptance to termination of IPO. Among them, Renhui biology, Chuangxin laser, Chuangxin laser and other enterprises terminated in the IPO registration stage, and the IPO queuing time was at the forefront; Lenovo Group, huimangwei, Rouyu technology and other enterprises have less queuing time. If the holiday factor is excluded, Lenovo Group has only one day from acceptance to termination. Huimangwei withdrew before the IPO declaration was inquired by the exchange, and the queue was only 33 days.
the 389 listed science and Innovation Board enterprises took an average of 274 days from acceptance to initial listing. among them, Weide information, No. 9 company, Wuhan Keqian Biology Co.Ltd(688526) , Wuhan Keqian Biology Co.Ltd(688526) , Liaoning Chengda Biotechnology Co.Ltd(688739) and other enterprises took 605 days, 561 days, 550 days, 548 days and 538 days respectively, ranking among the top; It takes relatively less time for {8561} and {6897} and {6881} days respectively.
the reporter of the science and Innovation Board daily noted that from the performance after listing, since the establishment of the science and innovation board, the number of enterprises that broke on the first day and whose current share price is lower than the issue price is tending to increase.
According to statistics, 19 enterprises broke off on the first day of listing, accounting for 4.9% of the total number of listed enterprises on the science and innovation board. Among them, Aojie technology and Maiwei biology fell the most on the first day of listing, exceeding 30%. With the exception of Luoyang Jalon Micro-Nano New Materials Co.Ltd(688357) , the remaining 18 first day breaking enterprises are listed after October 2021.
In terms of the cumulative increase and decrease after the listing of , 69 enterprises have been lower than the issuance price (former resumption of rights), accounting for 17.74% of the total number of listed enterprises on the science and innovation board. among them, Fujian Foxit Software Development Joint Stock Co.Ltd(688095) , Aojie technology, Maiwei biology, Maiwei biology and Baiji Shenzhou have fallen by 49.4%, 46.5%, 41.75%, 40.61% and 40.43% respectively compared with the issue price, and three companies have been listed after December 2021.
In terms of fund-raising, 389 listed science and Innovation Board enterprises raised a total net fund of 509.172 billion yuan, an increase of 19.89% over the planned fund-raising amount. 207 enterprises were over raised, accounting for 53.21% of the total. Among them, Hemai shares, Fujian Foxit Software Development Joint Stock Co.Ltd(688095) , Cansino Biologics Inc(688185) raised 869.02%, 534.93% and 397.95% respectively. The fund-raising of Orinko Advanced Plastics Co.Ltd(688219) , Kede Numerical Control Co.Ltd(688305) , Infovision Optoelectronics (Kunshan) Co.Ltd(688055) is lower than expected, and the fund-raising amount is less than 25% of the planned fund-raising amount.
